Literature DB >> 24076318

Murine models to study Clostridium difficile infection and transmission.

Trevor D Lawley1, Vincent B Young.   

Abstract

Clostridium difficile is the leading cause of antibiotic-associated diarrhea in healthcare facilities worldwide. C. difficile infections are difficult to treat because of the high rate of disease recurrence after antibiotic therapy, leaving few treatment options for patients. C. difficile is also difficult to contain within a healthcare setting due to a highly-transmissible, resistant spore form that challenges standard infection control measures. The recent development of murine infection models to study the interactions between C. difficile, the host and the microbiota are providing novel insight into the mechanisms of pathogenesis and transmission that should guide the development of therapies and intervention measures.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antibiotic-associated diarrhea; Clostridium difficile; Disease; Microbiota; Spore; Transmission

Mesh:

Year:  2013        PMID: 24076318      PMCID: PMC4089867          DOI: 10.1016/j.anaerobe.2013.09.008

Source DB:  PubMed          Journal:  Anaerobe        ISSN: 1075-9964            Impact factor:   3.331


  33 in total

1.  Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation.

Authors:  Les Dethlefsen; David A Relman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-16       Impact factor: 11.205

2.  Antibiotic treatment of clostridium difficile carrier mice triggers a supershedder state, spore-mediated transmission, and severe disease in immunocompromised hosts.

Authors:  Trevor D Lawley; Simon Clare; Alan W Walker; David Goulding; Richard A Stabler; Nicholas Croucher; Piero Mastroeni; Paul Scott; Claire Raisen; Lynda Mottram; Neil F Fairweather; Brendan W Wren; Julian Parkhill; Gordon Dougan
Journal:  Infect Immun       Date:  2009-06-29       Impact factor: 3.441

3.  Evolutionary dynamics of Clostridium difficile over short and long time scales.

Authors:  Miao He; Mohammed Sebaihia; Trevor D Lawley; Richard A Stabler; Lisa F Dawson; Melissa J Martin; Kathryn E Holt; Helena M B Seth-Smith; Michael A Quail; Richard Rance; Karen Brooks; Carol Churcher; David Harris; Stephen D Bentley; Christine Burrows; Louise Clark; Craig Corton; Vicky Murray; Graham Rose; Scott Thurston; Andries van Tonder; Danielle Walker; Brendan W Wren; Gordon Dougan; Julian Parkhill
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-05       Impact factor: 11.205

4.  Clostridium difficile infection in Europe: a hospital-based survey.

Authors:  Martijn P Bauer; Daan W Notermans; Birgit H B van Benthem; Jon S Brazier; Mark H Wilcox; Maja Rupnik; Dominique L Monnet; Jaap T van Dissel; Ed J Kuijper
Journal:  Lancet       Date:  2011-01-01       Impact factor: 79.321

5.  Use of purified Clostridium difficile spores to facilitate evaluation of health care disinfection regimens.

Authors:  Trevor D Lawley; Simon Clare; Laura J Deakin; David Goulding; Jennifer L Yen; Claire Raisen; Cordelia Brandt; Jon Lovell; Fiona Cooke; Taane G Clark; Gordon Dougan
Journal:  Appl Environ Microbiol       Date:  2010-08-27       Impact factor: 4.792

6.  A mouse model of Clostridium difficile-associated disease.

Authors:  Xinhua Chen; Kianoosh Katchar; Jeffrey D Goldsmith; Nanda Nanthakumar; Adam Cheknis; Dale N Gerding; Ciarán P Kelly
Journal:  Gastroenterology       Date:  2008-09-10       Impact factor: 22.682

7.  Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea.

Authors:  Alexander Khoruts; Johan Dicksved; Janet K Jansson; Michael J Sadowsky
Journal:  J Clin Gastroenterol       Date:  2010 May-Jun       Impact factor: 3.062

8.  Proteomic and genomic characterization of highly infectious Clostridium difficile 630 spores.

Authors:  Trevor D Lawley; Nicholas J Croucher; Lu Yu; Simon Clare; Mohammed Sebaihia; David Goulding; Derek J Pickard; Julian Parkhill; Jyoti Choudhary; Gordon Dougan
Journal:  J Bacteriol       Date:  2009-06-19       Impact factor: 3.490

9.  Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation.

Authors:  Dionysios A Antonopoulos; Susan M Huse; Hilary G Morrison; Thomas M Schmidt; Mitchell L Sogin; Vincent B Young
Journal:  Infect Immun       Date:  2009-03-23       Impact factor: 3.441

10.  The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing.

Authors:  Les Dethlefsen; Sue Huse; Mitchell L Sogin; David A Relman
Journal:  PLoS Biol       Date:  2008-11-18       Impact factor: 8.029

View more
  16 in total

Review 1.  Interactions Between the Gastrointestinal Microbiome and Clostridium difficile.

Authors:  Casey M Theriot; Vincent B Young
Journal:  Annu Rev Microbiol       Date:  2015       Impact factor: 15.500

2.  Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291.

Authors:  Jenessa A Winston; Rajani Thanissery; Stephanie A Montgomery; Casey M Theriot
Journal:  J Vis Exp       Date:  2016-12-10       Impact factor: 1.355

3.  Clostridium difficile-induced colitis in mice is independent of leukotrienes.

Authors:  Bruno C Trindade; Casey M Theriot; Jhansi L Leslie; Paul E Carlson; Ingrid L Bergin; Marc Peters-Golden; Vincent B Young; David M Aronoff
Journal:  Anaerobe       Date:  2014-09-16       Impact factor: 3.331

4.  A 3D intestinal tissue model supports Clostridioides difficile germination, colonization, toxin production and epithelial damage.

Authors:  Lamyaa Shaban; Ying Chen; Alyssa C Fasciano; Yinan Lin; David L Kaplan; Carol A Kumamoto; Joan Mecsas
Journal:  Anaerobe       Date:  2018-02-17       Impact factor: 3.331

Review 5.  Clostridium difficile infection.

Authors:  Wiep Klaas Smits; Dena Lyras; D Borden Lacy; Mark H Wilcox; Ed J Kuijper
Journal:  Nat Rev Dis Primers       Date:  2016-04-07       Impact factor: 52.329

6.  Dynamics and establishment of Clostridium difficile infection in the murine gastrointestinal tract.

Authors:  Mark J Koenigsknecht; Casey M Theriot; Ingrid L Bergin; Cassie A Schumacher; Patrick D Schloss; Vincent B Young
Journal:  Infect Immun       Date:  2014-12-22       Impact factor: 3.441

7.  Characterization of the Effects of Candida Gastrointestinal Colonization on Clostridioides difficile Infection in a Murine Model.

Authors:  Jesús A Romo; Carol A Kumamoto
Journal:  Methods Mol Biol       Date:  2022

8.  Environmental management in the gut: fecal transplantation to restore the intestinal ecosystem.

Authors:  Vincent B Young; Mary K Hayden
Journal:  Infect Dis (Lond)       Date:  2016-05-04

Review 9.  The roles of host and pathogen factors and the innate immune response in the pathogenesis of Clostridium difficile infection.

Authors:  Xingmin Sun; Simon A Hirota
Journal:  Mol Immunol       Date:  2014-09-18       Impact factor: 4.407

10.  Bacterial and Fungal Microbiota Changes Distinguish C. difficile Infection from Other Forms of Diarrhea: Results of a Prospective Inpatient Study.

Authors:  William Sangster; John P Hegarty; Kathleen M Schieffer; Justin R Wright; Jada Hackman; David R Toole; Regina Lamendella; David B Stewart
Journal:  Front Microbiol       Date:  2016-05-25       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.